日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CPX-351 vs daunorubicin, cytarabine, and gemtuzumab ozogamicin in older adults with non-adverse-risk AML: the NCRI AML18 trial

CPX-351 与柔红霉素、阿糖胞苷和吉妥珠单抗治疗老年非不良风险 AML 患者的疗效比较:NCRI AML18 试验

Knapper, Steven; Dillon, Laura W; Babu, Malavika; Thomas, Abin; Thomas, Ian; Hourigan, Christopher S; Andrew, Georgia; Dillon, Richard; Gilkes, Amanda; Marquez Almuina, Nuria; King, Sophie; McCarthy, Nicholas; Bahr, Reem; Al-Ali, Rasha W; Stone, Louisa; Coats, Tom; Byrne, Jennifer; Green, Simone; Overgaard, Ulrik Malthe; Sellar, Rob S; Dennis, Mike; Mehta, Priyanka; Hills, Robert; Freeman, Sylvie D; Russell, Nigel H

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial

根据老年 AML 患者的残余疾病状态,采用氟达拉滨、阿糖胞苷、粒细胞集落刺激因子和伊达比星,或克拉屈滨联合柔红霉素和阿糖胞苷强化治疗:来自 NCRI AML18 试验的结果

Russell, Nigel H; Thomas, Abin; Hills, Robert K; Thomas, Ian; Gilkes, Amanda; Almuina, Nuria Marquez; Burns, Sarah; Marsh, Lucy; Vyas, Paresh; Metzner, Marlen; McCarthy, Nicholas; Andrew, Georgia; Byrne, Jennifer; Sellar, Rob S; Kelly, Richard; Cahalin, Paul; Overgaard, Ulrik Malthe; Mehta, Priyanka; Dennis, Mike; Knapper, Steven; Freeman, Sylvie D

Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts

急性髓系白血病完全缓解(CR)伴部分血液学恢复(CRh)的临床评价:来自七个队列的7235例患者的报告

Appelbaum, Jacob S; Wei, Andrew H; Mandrekar, Sumithra J; Tiong, Ing S; Chua, Chong Chyn; Teh, Tse-Chieh; Fong, Chun Yew; Ting, Stephen B; Weber, Daniela; Benner, Axel; Hill, Hannah; Saadati, Maral; Yin, Jun; Stone, Richard M; Garcia-Manero, Guillermo; Erba, Harry P; Uy, Geoffrey L; Marcucci, Guido; Larson, Richard A; Thomas, Abin; Freeman, Sylvie D; Almuina, Nuria Marquez; Döhner, Konstanze; Thomas, Ian; Russel, Nigel H; Döhner, Hartmut; Othus, Megan; Estey, Elihu H; Walter, Roland B

Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial

吉妥珠单抗奥佐米星分次给药与单次给药治疗老年急性髓系白血病患者的获益决定因素:英国国家癌症研究所 (NCRI) AML18 试验

Freeman, Sylvie D; Thomas, Abin; Thomas, Ian; Hills, Robert K; Vyas, Paresh; Gilkes, Amanda; Metzner, Marlen; Jakobsen, Niels Asger; Kennedy, Alison; Moore, Rachel; Almuina, Nuria Marquez; Burns, Sarah; King, Sophie; Andrew, Georgia; Gallagher, Kathleen M E; Sellar, Rob S; Cahalin, Paul; Weber, Duruta; Dennis, Mike; Mehta, Priyanka; Knapper, Steven; Russell, Nigel H

Joint Diabetic Macular Edema Segmentation and Characterization in OCT Images

OCT图像中糖尿病性黄斑水肿的联合分割和特征分析

de Moura, Joaquim; Samagaio, Gabriela; Novo, Jorge; Almuina, Pablo; Fernández, María Isabel; Ortega, Marcos